Jonathan Chatzkel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Chatzkel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Chatzkel Today - Breaking & Trending Today

Tivozanib Plus Atezolizumab Under Investigation in Immunologically Cold Tumors

Published: March 24, 2023

The safety and efficacy of the immune checkpoint inhibitor atezolizumab plus the VEGF TKI tivozanib is being investigated in patients with unresectable or metastatic castrate-resistant prostate cancer, as well as those with several other immunologically cold tumors as part of the phase 1b/2 IMMCO-1 trial.

Source: onclive.com

Related Topics:

Jonathan ChatzkelUniversity Of Florida HealthUniversity Of Florida Data IntegrityDivision Of HematologyUniversity Of Florida College MedicineSafety CommitteeFlorida CollegeFlorida HealthData IntegrityAtezolizumab Plus Tivozanib Patients With Unresectable Or Metastatic Castrate Resistant Prostate CancerImmco 1 Trial